Mainboard
IPO ·
BSE, NSE
Gaudium IVF & Women Health Ltd
Listed
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.
Issue details
Price band
₹75 – ₹79
Face value
₹5
Lot size
189 shares
Minimum investment
₹14,931
Issue size
₹165.00 Cr
Fresh issue
₹90.00 Cr
Offer for sale
₹75.00 Cr
Issue type
Book Built
Exchange
BSE, NSE
Key dates
Opens
20 Feb 2026
Closes
24 Feb 2026
UPI mandate cut-off
5:00 PM on 24 Feb 2026
Allotment
25 Feb 2026
Refunds
25 Feb 2026
Shares in demat
26 Feb 2026
Listing
27 Feb 2026
Subscription and listing
Subscription
5.23x
Listing price
₹83
Registrar
Bigshare Services Pvt Ltd
Lead manager
Sarthi Capital Advisors
Subscription by category
Total
5.23x
Total applications
2,41,091
Anchor investors
Amount raised
₹49.50 Cr
Bid date
19 Feb 2026
50% lock-in ends
26 Mar 2026
Rest lock-in ends
25 May 2026
Listing day
Issue price
₹79
Open
₹83.00
High
₹87.15
Low
₹79.50
Day close
₹80.26
Listing gain at open
+5.06%
Issue structure
Shares reserved per category and share of the total issue
QIB Shares Offered
1,04,43,100
50.00%
Anchor Investor Shares Offered
62,65,860
30.00%
QIB (Ex. Anchor) Shares Offered
41,77,240
20.00%
NII Shares Offered
31,32,930
15.00%
bNII > ₹10L
20,88,620
10.00%
sNII < ₹10L
10,44,310
5.00%
Retail Shares Offered
73,10,170
35.00%
Total Shares Offered
2,08,86,200
100.00%
Finaccle’s quick read
Apply
FY25 income up 47%, PAT up 85%, ROE 21.25%, D/E 0.38, post-issue P/E 22.99x.
A rules-based screen of growth, margins, debt and valuation, built from the offer document and data on Chittorgarh.com. It is for information only and is not investment advice or a recommendation to buy or sell. Read the RHP and speak to a SEBI-registered adviser before you apply.
About the company
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India and have expanded into several states utilizing a hub-and-spoke model. The company operates over thirty locations, which include seven hubs (centres) and twenty-eight spokes. The organization has entered into a strategic alliance with Infertility Experts, known as Spokes, to achieve the mutual objective of raising awareness regarding Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments.
Founded
Promoters
Promoter holding
Financial performance
Period
PAT
ROE
21.25%
ROCE
21.03%
Debt / equity
0.38
PAT margin
25.14%
P/E post issue
22.99
Market cap
₹575.02 Cr
Use of IPO money
Funding capital expenditure towards establishment of New IVF Centers of the Company.
₹50.00 Cr
Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company.
₹20.00 Cr
General Corporate Purposes
₹12.28 Cr
Issue Expenses
₹14.15 Cr
Strengths
✓
Revenue up 47% in FY25 to ₹70.96 Cr
✓
PAT up 85% in FY25 to ₹19.13 Cr
✓
PAT margin of 25.14%
✓
ROE of 21.25% and ROCE of 21.03%
✓
Moderate leverage: debt to equity 0.38
Risks to watch
!
45% of the issue is an offer for sale by existing shareholders
Planning to take your own company public?
Every listing on this page started with a growing business that got its numbers, governance and paperwork ready for investors. If you are a promoter weighing an SME or main board IPO, we can tell you where you stand and what it will take.
Talk to our IPO Advisory team for readiness planning, or our IPO Consultancy team to run the listing end to end.
Last updated:
Information is compiled from exchange notices and the company’s offer document. It is for general information only and is not investment advice or a recommendation to apply. Read the prospectus before investing.